Cancer Institute A national cancer institute
designated cancer center

Stanford's Liver Cancer Expertise

As recognized leaders in the treatment of liver cancer, Stanford's Gastrointestinal (GI) Cancer Program offers both expertise and a broad range of treatment options. Innovative therapies include:

  • Advanced surgical techniques, including minimally invasive laparoscopic liver resection
  • Intraoperative Radiotherapy (IORT), using radiation to augment the effectiveness of surgery
  • Stereotactic Body Radiation Therapy (SBRT), a method for delivering precise doses of radiation with millimeter accuracy
  • Radiofrequency Ablation (RFA) and Microwave Ablation (MWA), minimally invasive procedure that use heat-generating, electrode-tipped needles to destroy tumors
  • Transarterial Chemoembolization (TACE), delivering chemotherapy directly to tumors and trapping it there, minimizing the toxicity of circulating chemotherapy
  • Radioembolization, a highly specialized treatment in which radioactive microspheres are injected into tumors to irradiate them from within

Stanford operates a dedicated weekly multi-specialty Hepatobiliary Tumor Board (Liver Tumor Board) attended by hepatobiliary surgeons, medical oncologists, interventional radiologists, radiation oncologists, transplant surgeons, diagnostic radiologists, and pathologists. Stanford also has a dedicated Asian Liver Center that offers outreach, education and research programs addressing the high incidence of hepatitis B and liver cancer in Asians and Asian Americans.

Additionally, Stanford's Gastrointestinal Cancer Program physicians lead the field in developing and testing new therapies to treat liver cancer. Some of the innovative therapies that Stanford physicians are offering to their patients through clinical trials include:

  • Antibody mediated immunotherapy: intratumoral ipilumumab
  • Targeted biological agents: ADI-PEG20, oncolytic viruses
  • New applications of radioembolization: metastatic colorectal cancer, tumor thrombus
  • Improved chemoembolization protocols: combination with systemic biologic therapy, use of drug-eluting beads

When appropriate, patients are invited to participate in studies of new treatments as well as large-scale multicenter clinical trials.

Stanford Medicine Resources:

Footer Links: